Search
Search
mobile logo
Title Image

LSK BioPharma at ASCO 2015

RELATED POSTS

Elevar reports positive Phase II data of adenoid cystic carcinoma therapy
Elevar Therapeutics Shares Results of Phase 2 Rivoceranib Trial in Patients with Progressive Recurrent or Metastatic Adenoid Cystic Carcinoma
Elevar Therapeutics Adds Drs. Honghui Zhou and David Lilienfeld as Vice Presidents
Elevar Therapeutics Announces Rivoceranib Demonstrated Clinical Effectiveness in Patients with Progressive Recurrent or Metastatic Adenoid Cystic Carcinoma in a Phase 2 Trial

Salt Lake City, UT    |    San Francisco, CA    |    Dublin, Ireland    |    Seoul, South Korea

© Copyright 2022 Elevar Therapeutics